Literature DB >> 15878006

Comparison of clinical presentation of acute myocarditis following smallpox vaccination to acute coronary syndromes in patients <40 years of age.

Robert E Eckart1, Eric A Shry, Samuel O Jones, J Edwin Atwood, John D Grabenstein.   

Abstract

Smallpox vaccine-associated myopericarditis may have a similar presentation to acute coronary syndrome (ACS). The clinical records of 78 young patients (<40 years of age) presenting with ACS (n = 16) or myocarditis after smallpox vaccination (n = 62) were reviewed. Comparisons were made among clinical presentation, cardiac enzymes, echocardiographic findings, and electrocardiographic changes. The presence of cardiac risk factors or focal wall motion abnormalities on echocardiography were associated with a diagnosis of ACS. There was a trend toward earlier elevation of troponin-I and creatine kinase in patients with myocarditis compared with ACS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878006     DOI: 10.1016/j.amjcard.2005.01.061

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Cardiac Adverse Events after Vaccination-A Systematic Review.

Authors:  Kanak Parmar; Sai Subramanyam; Gaspar Del Rio-Pertuz; Pooja Sethi; Erwin Argueta-Sosa
Journal:  Vaccines (Basel)       Date:  2022-04-29

2.  Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Authors:  Richard N Greenberg; Edgar Turner Overton; David W Haas; Ian Frank; Mitchell Goldman; Alfred von Krempelhuber; Garth Virgin; Nicole Bädeker; Jens Vollmar; Paul Chaplin
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226

3.  Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?

Authors:  Holger F Rabenau; Ingrid Rapp; Jochen Steinmann
Journal:  BMC Infect Dis       Date:  2010-06-23       Impact factor: 3.090

4.  Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.

Authors:  Eva-Maria Zitzmann-Roth; Frank von Sonnenburg; Stephan de la Motte; Nathaly Arndtz-Wiedemann; Alfred von Krempelhuber; Nadine Uebler; Jens Vollmar; Garth Virgin; Paul Chaplin
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

5.  Turkish Society of Cardiology consensus paper on the rational use of cardiac troponins in daily practice.

Authors:  Kaan Okyay; Beste Özben Sadıç; Asife Şahinarslan; Murtaza Emre Durakoğlugil; Can Yücel Karabay; Semiha Emel Eryüksel; Özlem Gülbahar; Abdullah Tekin; Aylin Yıldırır; Bülent Görenek; Oğuz Yavuzgil; Ali Serdar Fak
Journal:  Anatol J Cardiol       Date:  2019-04-19       Impact factor: 1.596

6.  Cardiac complication after experimental human malaria infection: a case report.

Authors:  An-Emmie Nieman; Quirijn de Mast; Meta Roestenberg; Jorien Wiersma; Gheorghe Pop; Anton Stalenhoef; Pierre Druilhe; Robert Sauerwein; André van der Ven
Journal:  Malar J       Date:  2009-12-03       Impact factor: 2.979

Review 7.  ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.

Authors:  Richard N Greenberg; Jeffrey S Kennedy
Journal:  Expert Opin Investig Drugs       Date:  2008-04       Impact factor: 6.498

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.